About: Keith Flaherty

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School. He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib. In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs.

Property Value
dbo:abstract
  • Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School. He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib. In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs. (en)
dbo:wikiPageID
  • 26306832 (xsd:integer)
dbo:wikiPageLength
  • 2034 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 919046868 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Keith Flaherty is director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School. He was previously a professor of medicine at the University of Pennsylvania. He is known for his research on targeted therapies for cancer, and in particular for his work on the melanoma drug vemurafenib. In 2013, Massachusetts General Hospital partnered with AstraZeneca to partner Flaherty's research into developing a formula to identify vulnerabilities of tumors with AstraZeneca's library of drugs. (en)
rdfs:label
  • Keith Flaherty (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:editor of
is dbo:wikiPageWikiLink of
is dbp:editor of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License